24/7 Market News Snapshot 30 September, 2025 – Qualigen Therapeutics, Inc. Common Stock (NASDAQ:QLGN)

September 30, 2025

DENVER, Colo., 30 September, 2025 (www.247marketnews.com) – (NASDAQ:QLGN) are discussed in this article.
Qualigen Therapeutics, Inc. has recently generated significant market interest, evidenced by a notable increase in pre-market trading where shares rose to $6.054, marking a 12.53% gain from the previous close of $5.38. This spike, accompanied by a trading volume of 1.86 million shares, reflects robust investor sentiment, possibly driven by anticipation of forthcoming positive developments for the company. As technical indicators suggest potential resistance testing above $6.50, market participants are advised to monitor volume trends alongside any relevant news catalysts that may influence price movements.

In a pivotal announcement, Qualigen disclosed the successful completion of a $41 million private investment in public equity (PIPE) financing. This transformative initiative was primarily backed by Faraday Future Intelligent Electric Inc., with support from major investors like the SIGN Foundation and Sequoia Capital. Faraday Future alone injected approximately $30 million, achieving a pro forma beneficial ownership of about 55%. The influx of capital is earmarked to propel Qualigen into an innovative new phase, as it prepares to rebrand as CXC10 and embrace a comprehensive Web3 and cryptocurrency strategy.

To spearhead this strategic shift, Qualigen has appointed Jerry Wang as Co-CEO and YT Jia as Chief Advisor. The rebranding is designed to optimize the company’s operations around advanced digital assets and will focus on six groundbreaking products, including the C10 Digital Asset Treasury and an AI-powered trading agent, BesTrade. These ventures aim to amplify market engagement and introduce offerings in Real World Assets and stablecoins, ultimately blending traditional finance with modern technological advancements.

“This financing represents a pivotal moment in Qualigen’s history, positioning us to initiate an ambitious transformation,” stated Kevin Richardson, Co-CEO. The commitment to balancing existing and new ventures ensures that Qualigen is strategically poised to thrive in the evolving economic environment.

Related news for (QLGN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.